Browse > Article
http://dx.doi.org/10.4014/jmb.0903.03027

Optimization of Capsular Polysaccharide Production by Streptococcus pneumoniae Type 3  

Jin, Sheng-De (School of Biological Sciences and Technology, Chonnam National University)
Kim, Young-Min (School of Biological Sciences and Technology, Chonnam National University)
Kang, Hee-Kyoung (The Research Institute for Catalysis, Chonnam National University)
Jung, Seung-Jin (Interdisciplinary Program of Graduate School for Bioenergy and Biomaterials, Chonnam National University)
Kim, Do-Man (School of Biological Sciences and Technology, Chonnam National University)
Publication Information
Journal of Microbiology and Biotechnology / v.19, no.11, 2009 , pp. 1374-1378 More about this Journal
Abstract
Response surface methodology (RSM) examining the effects of five-level-three-factors and their mutual interactions was utilized to optimize the fermentation conditions to enhance capsular polysaccharide (CPS) production of Streptococcus pneumoniae type 3. Twenty experiments conducted in an 8-l lab-scale fermentor were designed to assess fermentation pH, supplemented glucose concentration, and stirring rate. The predicted highest CPS production by the obtained optimization model equation was 256.14 mg/l at optimal conditions [pH 7.5, stirring rate 180 rpm, and supplemented glucose concentration 1% (w/v)]. The validity of the response model was confirmed by the good agreement between the predicted and experimental results. The maximum amount of CPS obtained was $255.03\pm2.23$ mg/l.
Keywords
Capsular polysaccharide; optimization; response surface methodology; Streptococcus pneumoniae; vaccine;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Arrecubieta, C., R. Lopez, and E. Garcia. 1996. Type 3-specific synthase of Streptococcus pneumoniae (Cap3B) directs type 3 polysaccharide biosynthesis in Escherichia coli and in pneumococcal strains of different serotypes. J. Exp. Med. 184: 449-455   DOI   ScienceOn
2 Chakravarti, R. and V. Sahai. 2002. Optimization of compactin production in chemically defined production medium by Penicillium citrinum using statistical methods. Proc. Biochem. 38: 481-486   DOI   ScienceOn
3 David, H. B. and J. G. Holt. 1994. Bergey's Manual of Determinative Bacteriology, pp, 480-496. 9th Ed. Williams & Wilkins, Philadelphia, Pennsylvania
4 Myers, C. and A. Gervaix, 2007. Streptococcus pneumoniae bacteraemia in children. Int. J. Antimicrob. Agents 308: S24-S28
5 Suarez, N., L. F. Fraguas, E. Texeira, H. Massaldi, F. BatisatViera, and F. Ferreira. 2001. Production of capsular polysaccharide of Streptococcus pneumoniae type 14 and its purification by affinity chromatography. Appl. Environ. Microbiol. 67: 969-971   DOI   ScienceOn
6 Forsee, W. T., R. T. Cartee, and J. Yother. 2000. Biosynthesis of type 3 capsular polysaccharide in Streptococcus pneumoniae. J. Biol. Chem. 275: 25972-25978   DOI   ScienceOn
7 Kim, S. N., K. K. Min, S. H. Kim, I. H. Choi, S. H. Lee, S. N. Pyo, and D. K. Rhee. 1996. Optimization of culture conditions for production of pneumococcal capsular polysaccharide type 1. J. Microbiol. 34: 179-183
8 Reeves, R. E. and W. F. Goebel. 1941. Chemoimmunological studies on the soluble specific substance of Pneumococcus. V. The structure of the type polysaccharide. J. Biol. Chem. 139: 511-519
9 WHO. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. 82: 93-104
10 CDC. 2000. Preventing pneumococcal disease among infants and young children: Recommendations of the Adivisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly. 49: 1-35
11 Dubois, M. A., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28: 350-356   DOI
12 Ashipala, O. K. and Q. He. 2008. Optimization of fibrinolytic enzyme production by Bacillus subtilis DC-2 in aqueous two-phase system (poly-ethylene glycol 4000 and sodium sulfate). Bioresour. Technol. 99: 4112-4119   DOI   ScienceOn
13 Michael, R. W., C. P. Lawrence, L. K. Dennis, L. D. Jose, M. Francis, H. Kevin, and J. J. Harold. 1990. Imrnunogenicity in animals of a polysaccharide-protein conjugate vaccine against Type III Group B Streptococcus. J. Clin. Invest. 86: 1428-1433   DOI   PUBMED   ScienceOn
14 Klein, J. O. 1981. The epidemiology of pneumococcal disease in infants and children. Rev. Infect. Dis. 3: 246-253   DOI   PUBMED
15 Gilbert, C., K. Robinson, R. W. F. Le Page, and J. M. Wells. 2000. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis. Infect. Immun. 68: 3251-3260   DOI   ScienceOn
16 Box, G. E. P. and K. B. Wilson. 1951. On the experimental attainment of optimum conditions (with discussion). J. R. Aust. Hist. Soc. Series B 13: 1-45
17 CDC. 1997. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly. 46: 1-24
18 Dillard, J. P. and J. Yother. 1991. Analysis of Streptococcus pneumoniae sequences cloned into Escherichia coli: Effect of promoter strength and transcription terminators. J. Bacteriol. 173: 5105-5109   PUBMED